SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $392 | – | 902 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 902 | -1.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 916 | -69.1% | 0.00% | – |
| Q1 2022 | $2,000 | -66.7% | 2,964 | -37.8% | 0.00% | – |
| Q4 2021 | $6,000 | -95.0% | 4,764 | -91.5% | 0.00% | – |
| Q3 2021 | $121,000 | -48.3% | 55,741 | -35.1% | 0.00% | – |
| Q2 2021 | $234,000 | -22.0% | 85,842 | -25.3% | 0.00% | – |
| Q1 2021 | $300,000 | – | 114,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |